Category

Daily Briefs

Daily Brief Equity Bottom-Up: 2026 High Conviction Idea: SK Inc and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • 2026 High Conviction Idea: SK Inc
  • Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN
  • NVIDIA Invests $2 Billion In Synopsys. But Why?
  • Meesho’s Valmo | Erosion of Delhivery’s Margins
  • JFE Holdings: India JV Resets Long-Term Growth Path; Deep Value with Structural Upside
  • Stockland (SGP AU) Vs. The GPT Group (GPT AU): Valuation Supports Long/Short Stat Arb Opportunity
  • Key Insights From Vale Day 2025: Strategy Recast for a New Metals Cycle
  • A Review of Korean Small Cap Gems in 2025
  • Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth
  • Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025


2026 High Conviction Idea: SK Inc

By Douglas Kim

  • Three main reasons why SK Inc is our high conviction in 2026 include mandatory cancellation of treasury shares, deep discount to NAV, and the end of divorce for Chairman Chey. 
  • SK Inc has 17.98 million shares in treasury, representing 24.8% of outstanding shares. Among the stocks included in KOSPI200, this is one of the highest percentage of treasury shares.
  • Our NAV valuation analysis suggests NAV of 28 trillion won or NAV per share of 386,469 won. This represents a 46% upside to its current price.

Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN

By Manishi Raychaudhuri

  • Since inception (May 15th), our Model Portfolio has appreciated 17.0% – same as MSCI Asia-ex Japan.  Since the last rebalancing (7th November) our Portfolio declined 2.5% vs MXASJ’s 1.3% drop.
  • The recent underperformance came from drawdowns in Tencent Music, Tencent, Alibaba, Hynix, Hyundai Rotem, TSMC. We reduce the first two slightly, exclude BBCA, include Adani Ports, SCB, MAPI, HK Land.
  • We remain Overweight HK/China and Korea. We upgrade India to Overweight from Neutral, Thailand from Underweight to Neutral, and downgrade Indonesia to Underweight from Neutral. Stay Underweight Taiwan, Neutral Singapore.

NVIDIA Invests $2 Billion In Synopsys. But Why?

By William Keating

  • NVIDIA & Synopsys announced a new strategic partnership on Dec 1, mostly covering topics they were already strategically partnering on, with one exception, Cloud-Ready Solutions
  • The partnership sees NVIDIA purchase $2 billion worth of Synopsys stock in a private placement. Other, recent, similar strategic partnerships e.g. Siemens & GM, involved no such investment
  • They plan to start enabling cloud access for GPU-accelerated engineering solutions. Could this be where that $2 billion finds a home? Is this a new Neocloud in disguise? Let’s see

Meesho’s Valmo | Erosion of Delhivery’s Margins

By Pranav Bhavsar

  • Delhivery (DELHIVER IN) faces immediate volume erosion as Meesho (1546271D IN) migrates 65% of orders to Valmo, destabilizing a key client relationship historically contributing ~16% of total revenue.
  • Valmo’s rise structurally shrinks the addressable 3PL market, creating a permanent headwind that compresses pricing power and intensifies competition for remaining open volumes.
  • Anchor client insourcing caps Delhivery’s growth trajectory, rendering the Ecom Express acquisition insufficient to offset the structural decay in organic B2C volume velocity.

JFE Holdings: India JV Resets Long-Term Growth Path; Deep Value with Structural Upside

By Rahul Jain

  • BPSL JV gives JFE a scalable India platform, shifting long-term growth away from a stagnant Japan market.
  • Balance-Sheet impact is manageable, with optional liquidity from the ¥500 bn JSW stake.
  • Valuation deeply discounted at 0.5× P/B and US$525/t despite rising mix, India optionality, and multi-year earnings normalization.

Stockland (SGP AU) Vs. The GPT Group (GPT AU): Valuation Supports Long/Short Stat Arb Opportunity

By Gaudenz Schneider

  • Context: The GPT Group (GPT AU) vs. Stockland (SGP AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Stockland (SGP AU) and short The GPT Group (GPT AU) targets a 4% return, with Stockland (SGP AU) supported by a lower P/E multiple.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Key Insights From Vale Day 2025: Strategy Recast for a New Metals Cycle

By Umang Agrawal

  • Vale cuts 2026 iron ore guidance to 335–345 Mt as China’s weaker demand and rising scrap reduce seaborne needs by about 160 Mt.
  • Steel decarbonisation accelerates through global EAF expansion, pushing Vale toward a flexible blend of high-grade, mid-grade, and corrective ores to maximise value.
  • Vale and Glencore’s Sudbury study targets 880 kt copper over 21 years, leveraging shared infrastructure to curb costs and bolster North American supply.

A Review of Korean Small Cap Gems in 2025

By Douglas Kim

  • In this insight, we review our Korean Small Cap Gem insights that we published in 2025. We published 18 Korea Small Cap Gem Series insights in 2025.
  • The 18 Korean Small Caps have generally performed well this year. They were up on average 17% and 45%, respectively one week and two weeks after the insights were published.
  • Some of the best performing stocks so far this year include Chunil Express (000650 KS), Aurora World (039830 KS), Makus Inc (093520 KS), and Flitto Inc. (300080 KS). 

Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth

By Mohshin Aziz

  • Tuhu sets up operations in Malaysia, its first overseas expansion outside of Greater China.
  • We think Tuhu can dominate the market within 3-4 years, as there are no local establishments that can match its infrastructure, know-how, and capital base. 
  • Fair value of HKD23 implies 22x FY26 PE – average for US peers. A bargain with 3-year CAGR of 30%, net cash, and churns high free cash flow.

Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025

By Sessa Investment Research

  • On November 13, Geechs Inc. (hereafter, “the Company”) announced its Q2 FY2026/3 (Jul-Sep) earnings results.
  • Net sales rose 2.5% YoY to JPY 6,518 mn, EBITDA rose 86% YoY to JPY 278 mn, and operating profit rose 124.9% YoY to JPY 253 mn.
  • In addition to steady expansion of the core Japan IT Human Resources Matching Business (hereafter, “Japan IT HRM Biz”), faster-than-expected profitability in the IT Human Resources Matching Business, Overseas (hereafter, “Overseas IT HRM Biz”) and stronger-than-planned growth in the Seed Tech business contributed to results. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Synopsys Inc, Legalzoom.com , Crude Oil, Futu Holdings Ltd, Olin Corp, Vera Bradley, C3.ai Inc, Build A Bear Workshop and more

By | Daily Briefs, United States

In today’s briefing:

  • NVIDIA Invests $2 Billion In Synopsys. But Why?
  • Primer: Legalzoom.com (LZ US) – Dec 2025
  • 2026 High Conviction Idea: Our Basket of Commodity Equities Will Outperform Broad Equity Indices
  • Primer: Futu Holdings Ltd (FUTU US) – Dec 2025
  • Primer: Olin Corp (OLN US) – Dec 2025
  • VRA: 3Q Preview: Hints of What’s to Come; Reiterate Hold
  • C3.ai, Inc. – IPDs and the Gross Margin Squeeze
  • Oil futures: Crude touches weekly highs on geopolitical tensions
  • BBW: 3Q Review: Tariffs To Be Even Further Drag into FY26; Lowering EPS & PT


NVIDIA Invests $2 Billion In Synopsys. But Why?

By William Keating

  • NVIDIA & Synopsys announced a new strategic partnership on Dec 1, mostly covering topics they were already strategically partnering on, with one exception, Cloud-Ready Solutions
  • The partnership sees NVIDIA purchase $2 billion worth of Synopsys stock in a private placement. Other, recent, similar strategic partnerships e.g. Siemens & GM, involved no such investment
  • They plan to start enabling cloud access for GPU-accelerated engineering solutions. Could this be where that $2 billion finds a home? Is this a new Neocloud in disguise? Let’s see

Primer: Legalzoom.com (LZ US) – Dec 2025

By αSK

  • LegalZoom is the market leader in the online legal services industry, benefiting from strong brand recognition and a large customer base. The company is strategically shifting its focus towards higher-margin subscription services to create a more predictable, recurring revenue stream.
  • The company exhibits a strong financial profile with consistent revenue growth, expanding EBITDA margins, and a debt-free balance sheet. This financial stability supports investments in technology, strategic acquisitions, and share repurchase programs.
  • Key risks to the outlook include intense competition from both established players and new entrants, potential regulatory changes concerning the unauthorized practice of law, and a high dependency on the macroeconomic environment which influences the rate of new business formations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


2026 High Conviction Idea: Our Basket of Commodity Equities Will Outperform Broad Equity Indices

By Rikki Malik

  • The current macro environment has elements of both the 1970’s and mid-2000s commodity bull market
  • Investor interest and allocation to this asset class is still minimal
  • A rising cost of capital globally favours a move out of long duration into real assets

Primer: Futu Holdings Ltd (FUTU US) – Dec 2025

By αSK

  • Futu Holdings is a high-growth, technology-driven online brokerage and wealth management platform with a strong foothold in Hong Kong and expanding international operations.
  • The company has demonstrated exceptional financial performance, characterized by robust revenue and net income growth, and superior profit margins compared to industry peers, driven by a scalable business model.
  • Significant regulatory risks, particularly concerning its mainland China client base and the evolving cross-border financial services landscape, remain a key uncertainty and a primary concern for investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Olin Corp (OLN US) – Dec 2025

By αSK

  • Olin Corp. is a leading, vertically integrated global manufacturer of chemical products and ammunition, operating through its Chlor Alkali Products and Vinyls, Epoxy, and Winchester segments.
  • The company is navigating a challenging petrochemical environment by focusing on a U.S.-centric sales strategy and prioritizing cash generation and shareholder returns, which has allowed it to outperform peers.
  • Financial performance has been under pressure, with declining revenue and net income over the past three years, reflecting weak demand, low prices, and higher input costs in the broader chemical sector.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


VRA: 3Q Preview: Hints of What’s to Come; Reiterate Hold

By Small Cap Consumer Research

  • We are reiterating our Hold rating and projections for Vera Bradley with the company announcing 3QFY26 (October) results before the open on Thursday, December 11th.
  • Given the continuing initial shifts under new management (who joined in July) and the limited ability to change product offerings until 1Q2026 (at the earliest), we believe overall financial results are not as important as are customer responses to the shift back to heritage looks, the return of key silhouettes, the launch of Outlet 2.0 at the end of the quarter and what further changes are in store going forward.
  • We continue to view the changes as a positive, but await clarification on the overall implications for the company (and returns) before becoming more aggressive in VRA.

C3.ai, Inc. – IPDs and the Gross Margin Squeeze

By Water Tower Research

  • In-line 2QFY26 revenue and EBIT beat on cost controls, but gross margin pressure from IPDs. 
  • 2QFY26 revenue of $75.1 million was essentially on target and cost controls drove a better-than-expected bottom line with EBIT of ($42 million) [Street = ($52 million)]. 
  • However, non-GAAP gross margin was 54.5%, up 280 bps but more than 300 bps below Street expectations.

Oil futures: Crude touches weekly highs on geopolitical tensions

By Quantum Commodity Intelligence

  • Crude oil futures on Thursday were climbing higher, as benchmarks maintained the firmer start to December, albeit amid conflicting signals.
  • Front-month Feb26 ICE Brent futures were trading at $63.31/b (2033 GMT) versus Wednesday’s settle of $62.67/b, while Jan26 NYMEX WTI was at $ 59.72/b against a previous close of $58.95/b.
  • Prices have found some support this week from the fading prospects of a ceasefire in the Russia-Ukraine conflict and the broader rise in geopolitical tensions, but it has not been enough to shake off the gloom around a growing surplus.

BBW: 3Q Review: Tariffs To Be Even Further Drag into FY26; Lowering EPS & PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, but lowering our projections and reducing our price target of BBW to $65 (from $75) after Build-A-Bear reported solid 3Q EBITDA & EPS upside, but lighter than expected revenue, and implied deep tariff impacts into 1HFY26 will serve to offset near-term positives and materially impact operating results.
  • 3Q tariffs negatively impacted the company by $4 million (or a projected $0.23 in EPS) with a $6 million further negative impact in 4Q (projected $0.35 in EPS) and, we believe approximately $7 million to $9 million (projected $0.41 to $0.53 in EPS) in the first five months of FY26.
  • While we view this scenario as potentially conservative, we have to face the facts that overall gross margins, if tariff impacts remain similar to 2HFY25 in 1HFY26 without any further material offsets, will significantly decline.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: BoE Survey Says Stagflation Survives and more

By | Daily Briefs, Macro

In today’s briefing:

  • BoE Survey Says Stagflation Survives
  • Activity Thaws Into Winter
  • Late-Cycle Tension: Rising Volatility Signals a Critical Market Inflection into 2026
  • 2026 High Conviction Idea: Our Basket of Commodity Equities Will Outperform Broad Equity Indices
  • CX Daily: Shenzhen Gorged on Skyscrapers, Now It Faces a Commercial Property Glut
  • Oil futures: Crude touches weekly highs on geopolitical tensions
  • Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 5 Dec 2025


BoE Survey Says Stagflation Survives

By Phil Rush

  • CFOs keep telling the BoE their prices will rise by 3.5% in 2026, with wage increases similarly substantial. There has been no significant break lower in over 18 months.
  • Employment plans have also deteriorated, lending some support to the dovish case as well. But this side is an unreliable signal, while inflation has proved brutally accurate.
  • Doves need the employment aspect to be true, but the transmission to prices not to be. This survey signals upside inflation risks that should discourage rate cuts in 2026.

Activity Thaws Into Winter

By Phil Rush

  • The worst services PMIs thawed in November, broadening growth even as averages held steady. Activity in the US services ISM has trended up to exceed the PMI data now.
  • A slight fading of stagflationary pressures in the latest US surveys probably balances out in the Fed’s policy trade-off. We still fear that it is easing excessively.
  • Rising unemployment rates in the US and UK are concerns not experienced in most of the world. This theme feeds their recent divergence from the global surprise tendency.

Late-Cycle Tension: Rising Volatility Signals a Critical Market Inflection into 2026

By Ron William

  • US equities triggered key reversal signals as market breadth deteriorated, crowded AI leaders unwound, and indexes broke trend support, elevating near-term downside risk. 
  • Macro uncertainty, tighter liquidity, and shifting investor psychology are pressuring high-liquidity growth assets, while gold and quality balance-sheet exposures provide relative resilience. 
  • Multiple late-cycle timing models align into early 2026, raising the probability of episodic volatility and making disciplined positioning, selective risk-taking, and tactical hedging essential.

2026 High Conviction Idea: Our Basket of Commodity Equities Will Outperform Broad Equity Indices

By Rikki Malik

  • The current macro environment has elements of both the 1970’s and mid-2000s commodity bull market
  • Investor interest and allocation to this asset class is still minimal
  • A rising cost of capital globally favours a move out of long duration into real assets

CX Daily: Shenzhen Gorged on Skyscrapers, Now It Faces a Commercial Property Glut

By Caixin Global

  • In Depth: Shenzhen Gorged on Skyscrapers, Now It Faces a Commercial Property Glut
  • ICBC Executives Taken Away as Concerns Mount Over China’s Biggest Bank
  • PBOC Injects 50 Billion Yuan in November to Steady Year-End Liquidity

Oil futures: Crude touches weekly highs on geopolitical tensions

By Quantum Commodity Intelligence

  • Crude oil futures on Thursday were climbing higher, as benchmarks maintained the firmer start to December, albeit amid conflicting signals.
  • Front-month Feb26 ICE Brent futures were trading at $63.31/b (2033 GMT) versus Wednesday’s settle of $62.67/b, while Jan26 NYMEX WTI was at $ 59.72/b against a previous close of $58.95/b.
  • Prices have found some support this week from the fading prospects of a ceasefire in the Russia-Ukraine conflict and the broader rise in geopolitical tensions, but it has not been enough to shake off the gloom around a growing surplus.

Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 5 Dec 2025

By Dr. Jim Walker

  • United States shows deepening slowdown with weak ISM manufacturing, falling employment, and declining private payrolls, signaling rising recession risk.

  • India and China exhibit relatively constructive economic prospects, contrasting with softness in advanced economies.

  • Asian indicators are mixed, with Indonesia struggling on trade and Hong Kong retail sales recovering gradually but remaining below pre-COVID levels.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Dongfeng Motor, ANE Cayman Inc, Shenzhen Mindray Bio-Medical Electronics, Tuhu Car , Futu Holdings Ltd, Guangdong Tianyu Semiconductor and more

By | China, Daily Briefs

In today’s briefing:

  • Dongfeng (489 HK): Revisiting VOYAH’s Spin-Off Valuation
  • ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?
  • Shenzhen Mindray Bio-Medical A/H Listing-Strong Track Record but Has Been Suffering Lately
  • Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth
  • 2026 High Conviction Idea – FUTU US – 3Q25 Beat and Bottom-Of-Range Valuation Creates Strong Upside
  • Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand


Dongfeng (489 HK): Revisiting VOYAH’s Spin-Off Valuation

By David Blennerhassett

  • Back on the 22nd August 2025, SOE-backed Dongfeng Motor (489 HK) announced a privatisation; together with a concurrent listing of its EV arm, VOYAH. The two proposals are interconditional.
  • In its October application proof, VOYAH turned a profit in 7M25.  The market was implying a price-to-trailing-sales of 1.5x for VOYAH, versus the basket average of 2.1x. It’s now ~1.2x.
  • Key PRC reg approvals (Mofcom/NDRC/SAFE) remain outstanding. Meanwhile, a basket of peers are down 21% since the dual proposals were announced. And their average price-to-trailing-sales are down to 1.7x. 

ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?

By Arun George

  • The consortium has decided NOT to exercise its right to increase the ANE Cayman Inc (9956 HK) share alternative cap from 5.00% to 7.50% of outstanding shares. 
  • The positive read-across is that it signals the consortium’s confidence that the vote will pass, as reflected in the quick decision not to lift the cap (deadline was 12 December). 
  • The negative readacross is that shareholders requesting the scrip option likely exceeded the 7.5% upper threshold, and the consortium is hoping that these shareholders will instead take the mix option.

Shenzhen Mindray Bio-Medical A/H Listing-Strong Track Record but Has Been Suffering Lately

By Sumeet Singh

  • Shenzhen Mindray Bio-Medical Electronics (300760 CH) (SMBE), a provider of medical devices, is looking to raise about US$2bn in its upcoming H-share IPO
  • SMBE is a diversified global medical device enterprise with its products spanning In Vitro Diagnostics (IVD), patient monitoring and life support, medical imaging, along with an emerging business portfolio.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth

By Mohshin Aziz

  • Tuhu sets up operations in Malaysia, its first overseas expansion outside of Greater China.
  • We think Tuhu can dominate the market within 3-4 years, as there are no local establishments that can match its infrastructure, know-how, and capital base. 
  • Fair value of HKD23 implies 22x FY26 PE – average for US peers. A bargain with 3-year CAGR of 30%, net cash, and churns high free cash flow.

2026 High Conviction Idea – FUTU US – 3Q25 Beat and Bottom-Of-Range Valuation Creates Strong Upside

By Raj S, CA, CFA

  • FUTU’s risk-reward is asymmetric:  Structurally low valuation, active consensus upgrades and a near-term catalyst (HK crypto VATP license), which can boost further upgrades (2026e) sets up a compelling long entry.
  • HK-VATP enables FUTU to expand its crypto related revenues, product offerings and margins, and remove third-party dependency. With crypto <2% assets, this new earnings leg is entirely absent from consensus.
  • FUTU’s pullback to ~15.6x FY2 P/E puts it at the bottom of a ~15x-25x – reasonable valuation band. With upgrades and catalysts ahead, it stands as a strong rerating candidate.

Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand

By Nicholas Tan

  • Guangdong Tianyu Semiconductor (2223725D CH) raised around US$224m in its HK IPO.
  • It was founded in 2009, and is the largest domestic PRC SiC epitaxal wafer manufacturer both in terms of revenue and sales volume, as of 2024.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Adani Ports & Special Economic Zone, Meesho, Greenko Energy Holdings, Ambuja Cements and more

By | Daily Briefs, India

In today’s briefing:

  • Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN
  • Meesho Ltd IPO- Watch Out for Impairment Allowance
  • Meesho Ltd IPO – Value-Led Play, Moderately Priced
  • Meesho’s Valmo | Erosion of Delhivery’s Margins
  • Meesho:Data Science Workhorse;Fast Evolving—Venturing into Financial Services & Other AI Investments
  • Lucror Analytics – Morning Views Asia
  • The Beat Ideas: Ambuja Cements From Consolidation to Cost Leadership – Unpacking the 155 MTPA Plan


Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN

By Manishi Raychaudhuri

  • Since inception (May 15th), our Model Portfolio has appreciated 17.0% – same as MSCI Asia-ex Japan.  Since the last rebalancing (7th November) our Portfolio declined 2.5% vs MXASJ’s 1.3% drop.
  • The recent underperformance came from drawdowns in Tencent Music, Tencent, Alibaba, Hynix, Hyundai Rotem, TSMC. We reduce the first two slightly, exclude BBCA, include Adani Ports, SCB, MAPI, HK Land.
  • We remain Overweight HK/China and Korea. We upgrade India to Overweight from Neutral, Thailand from Underweight to Neutral, and downgrade Indonesia to Underweight from Neutral. Stay Underweight Taiwan, Neutral Singapore.

Meesho Ltd IPO- Watch Out for Impairment Allowance

By Nitin Mangal

  • Meesho (1546271D IN)‘s INR 52.4 bn IPO is currently open for subscription. It consists of fresh issue worth INR 42.5 bn and OFS component worth INR 11.7 bn 
  • The company is India’s largest E-Com platforms in terms of placed orders and user base, and make its mark in the value segment, offering mostly unbranded and regional branded products. 
  • While KPIs signal growth and operational efficiencies, Meesho is still a loss maker. It has high litigation risk and seeing rapid increase in impairments and write offs with receivables

Meesho Ltd IPO – Value-Led Play, Moderately Priced

By Akshat Shah

  • Meesho (1546271D IN) is looking to raise around US$607m in its upcoming India IPO.
  • Meesho is an e-commerce marketplace, offering a wide assortment of products ranging from low cost unbranded products, regional and national brands at affordable prices to consumers.
  • In our earlier notes, we have looked at the company’s past performance earlier. In this note, we talk about the implied valuations in the price range.

Meesho’s Valmo | Erosion of Delhivery’s Margins

By Pranav Bhavsar

  • Delhivery (DELHIVER IN) faces immediate volume erosion as Meesho (1546271D IN) migrates 65% of orders to Valmo, destabilizing a key client relationship historically contributing ~16% of total revenue.
  • Valmo’s rise structurally shrinks the addressable 3PL market, creating a permanent headwind that compresses pricing power and intensifies competition for remaining open volumes.
  • Anchor client insourcing caps Delhivery’s growth trajectory, rendering the Ecom Express acquisition insufficient to offset the structural decay in organic B2C volume velocity.

Meesho:Data Science Workhorse;Fast Evolving—Venturing into Financial Services & Other AI Investments

By Sreemant Dudhoria,CFA

  • In this insight, we highlight why Meesho (1546271D IN) is a data science workhorse masquerading as an E-Commerce Platform
  • We discuss about the various advancements made by the company towards AL/ML models which are difficult to replicate.
  • Finally, we discuss our view on future prospects and valuation of the company.

Lucror Analytics – Morning Views Asia

By Trung Nguyen

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Greenko Energy, New World Development
  • UST yields fell 2-3 bps yesterday, following the release of weaker than expected November ADP payrolls data. The yield on the 2Y and 10Y UST declined 2 bps to 3.49% and 4.06%, respectively. Equities rose, as the labour market slowdown reinforced market expectations for a Fed rate cut this month. The S&P 500 advanced 0.3% to 6,850, while the Nasdaq was up 0.2% at 23,454.
  • In the US, the ADP employment report showed that private-sector payrolls declined by 32 k in November (10 k e / 47 k revised p), with payrolls having fallen in four of the past six months. Hiring has been choppy of late, as employers weather cautious consumers and an uncertain macroeconomic environment, according to ADP chief economist Nela Richardson. While the November slowdown was broad-based, it was led by a pullback among small businesses.

The Beat Ideas: Ambuja Cements From Consolidation to Cost Leadership – Unpacking the 155 MTPA Plan

By Nimish Maheshwari

  • Ambuja Cements (ACEM) has raised its FY28 capacity target to 155 million tonnes per annum and secured the acquisition of Jaiprakash Associates’ (JAL) cement business.
  • This aggressive scale-up, underpinned by a target cost reduction of INR 550/t and a green power push, is expected to drive EBITDA to INR 15000/t over FY26-28E.
  • ACEM’s integrated strategy of inorganic growth and operational efficiency suggests a strong re-rating potential, justifying a deeper review of core fundamentals.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: SBI Shinsei Bank, Nikkei 225, Tsuruha Holdings, JFE Holdings, Geechs Inc, Itoki Corp, Kyowa Kirin Co Ltd, Isamu Paint, Smk Corp, Sysmex and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Japan IPO] The SBI Shinsei Bank (8303 JP) IPO; Cosmetically Pretty, Otherwise Meh
  • 2026 High Conviction – Japan’s Triple Play: How PBR Reform, AI, and Banks Unlock Alpha
  • Tsuruha-Welcia: Will Scale Translate into Profit?
  • JFE Holdings: India JV Resets Long-Term Growth Path; Deep Value with Structural Upside
  • Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025
  • Itoki (7972 JP) – Capturing Structural Growth in the Future of Work
  • Kyowa Kirin (4151 JP): Ziftomenib Approval and Commercialization A Positive, What Lies Ahead?
  • Primer: Isamu Paint (4624 JP) – Dec 2025
  • (04 Dec 2025) Smk Corp(6798 JP) — Fisco Company Research
  • Primer: Sysmex (6869 JT) – Dec 2025


[Japan IPO] The SBI Shinsei Bank (8303 JP) IPO; Cosmetically Pretty, Otherwise Meh

By Travis Lundy

  • The SBI Shinsei Bank (8303 JP) IPO is due to be priced on 8 December and start trading on 17 December 2025.
  • I have been reluctant to write because of my general lack of excitement regarding the IPO and its after-market prospects. It is, as a friend says, “neither here nor there.”
  • But as the bank was my High Conviction Long trade for 2021, 2022, and 2023 and I wrote about the events in the interim, I thought I should opine.

2026 High Conviction – Japan’s Triple Play: How PBR Reform, AI, and Banks Unlock Alpha

By Jay Cameron

  • Sustained pressure from the JPX initiative targeting firms trading below P/B is forcing enhanced capital returns (buybacks and dividends), creating opportunity across both indices.
  • BoJ’s shift to a positive rate environment is fundamentally restoring Net Interest Income and profitability to the Financials sector, positioning the TOPIX, in particular, for outperformance.
  • AI/Tech Sector Dominance: The Nikkei 225 is driven by high-tech firms. This concentration, led by high-priced high weighted stocks like Advantest and Softbank Group, provides high-beta AI exposure

Tsuruha-Welcia: Will Scale Translate into Profit?

By Michael Causton

  • The Tsuruha and Welcia merger before the year’s close, backed by Aeon, is targeting ¥50 billion in cost savings over three years. 
  • As well as the massive economies of scale, consolidated procurement, revamped private brands and a unified points and customer‑ID strategy are central to this.
  • However, weak food offerings, legacy stores and IT complexity still threaten sustainable profit recovery as is the question of who will be in charge.

JFE Holdings: India JV Resets Long-Term Growth Path; Deep Value with Structural Upside

By Rahul Jain

  • BPSL JV gives JFE a scalable India platform, shifting long-term growth away from a stagnant Japan market.
  • Balance-Sheet impact is manageable, with optional liquidity from the ¥500 bn JSW stake.
  • Valuation deeply discounted at 0.5× P/B and US$525/t despite rising mix, India optionality, and multi-year earnings normalization.

Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025

By Sessa Investment Research

  • On November 13, Geechs Inc. (hereafter, “the Company”) announced its Q2 FY2026/3 (Jul-Sep) earnings results.
  • Net sales rose 2.5% YoY to JPY 6,518 mn, EBITDA rose 86% YoY to JPY 278 mn, and operating profit rose 124.9% YoY to JPY 253 mn.
  • In addition to steady expansion of the core Japan IT Human Resources Matching Business (hereafter, “Japan IT HRM Biz”), faster-than-expected profitability in the IT Human Resources Matching Business, Overseas (hereafter, “Overseas IT HRM Biz”) and stronger-than-planned growth in the Seed Tech business contributed to results. 

Itoki (7972 JP) – Capturing Structural Growth in the Future of Work

By Astris Advisory Japan

  • Structural demand meets sustained value creation – The role of the office is undergoing a structural shift—driven by talent attraction, hybrid work, wellness, and technology.
  • As a key domestic player in office design and furniture, we believe Itoki is well-positioned to benefit from this structural theme.
  • Post-COVID demand momentum remains steady, supported by rising investment in human capital, persistent labour shortages, and limited new office supply. 

Kyowa Kirin (4151 JP): Ziftomenib Approval and Commercialization A Positive, What Lies Ahead?

By Tina Banerjee

  • Kyowa Kirin Co Ltd (4151 JP) announced that ziftomenib is now commercially available in the U.S. Company will be eligible for 50% profit sharing from drug sales in the U.S.
  • Rocatinlimab, under Phase 3 trials, represents a potentially novel upstream approach for the management of mild to severe atopic dermatitis. It is also undergoing Phase 3 trials for Prurigo nodularis.
  • 2026 will be an inflection point. Ziftomenib results will slowly fall in place. Positive results of rocatinlimab and new manufacturing facilities has potential to play out in long term.

Primer: Isamu Paint (4624 JP) – Dec 2025

By αSK

  • Isamu Paint is a specialized Japanese manufacturer with a primary focus on high-quality automotive refinish paints, complemented by industrial and architectural coatings.
  • The company exhibits solid financial health, characterized by consistent revenue and net income growth over the past three years, alongside a strong balance sheet indicated by a high resilience score.
  • Valuation appears attractive, with the company trading at a significant discount to its larger peers on key metrics like P/E and EV/EBITDA, suggesting a potential value opportunity for investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


(04 Dec 2025) Smk Corp(6798 JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • SMK Co., Ltd. reported an operating loss in the first half of the fiscal year ending March 2026, but its net loss improved.
  • The company, celebrating its centenary in April 2025, is a key manufacturer of electronic components in Japan.
  • SMK maintains a competitive edge by focusing on high-functionality custom products and has a 65.1% overseas sales ratio.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Primer: Sysmex (6869 JT) – Dec 2025

By αSK

  • Sysmex is a global leader in the in-vitro diagnostics (IVD) market, with a dominant position in the hematology segment and a strong presence in urinalysis and hemostasis. The company’s business model is driven by the sale of diagnostic instruments and the recurring revenue from high-margin reagents.
  • Growth is supported by favorable long-term trends, including aging populations, rising prevalence of chronic diseases, and increasing healthcare access in emerging markets. Sysmex is strategically focused on expanding its footprint in these high-growth regions, particularly in Asia.
  • While the company has a strong track record of revenue growth and profitability, it faces challenges from intensifying competition, pricing pressure from healthcare cost-containment measures, and the need for continuous innovation to maintain its technological edge.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Shenzhen Mindray Bio-Medical Electronics, Cleanspace Holdings Ltd, UltraGreen.AI, JTEC Corp/Osaka, Kyowa Kirin Co Ltd, Sysmex and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Shenzhen Mindray Bio-Medical A/H Listing-Strong Track Record but Has Been Suffering Lately
  • Cleanspace Holdings Ltd – Several headwinds slow growth in H1
  • Primer: UltraGreen.AI (ULG SP) – Dec 2025
  • JTEC Corp (3446 JP) – Strength in Optical Remains, Progress in Semiconductor
  • Kyowa Kirin (4151 JP): Ziftomenib Approval and Commercialization A Positive, What Lies Ahead?
  • Primer: Sysmex (6869 JT) – Dec 2025


Shenzhen Mindray Bio-Medical A/H Listing-Strong Track Record but Has Been Suffering Lately

By Sumeet Singh

  • Shenzhen Mindray Bio-Medical Electronics (300760 CH) (SMBE), a provider of medical devices, is looking to raise about US$2bn in its upcoming H-share IPO
  • SMBE is a diversified global medical device enterprise with its products spanning In Vitro Diagnostics (IVD), patient monitoring and life support, medical imaging, along with an emerging business portfolio.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Cleanspace Holdings Ltd – Several headwinds slow growth in H1

By RaaS Research Group (RaaS)

  • CleanSpace Holdings Ltd (ASX:CSX) is a designer and manufacturer of respiratory protection equipment and consumables for powered air purifying respirators (PAPRs).
  • CSX has provided a trading update at their AGM which guides to lower H1 FY26 revenue growth relative to previous halves and RaaS estimates (+27%), impacted by trade and tariff tensions not dis-similar to trends seen for several advanced Australian manufacturers including Veem (ASX:VEE) and Austin Engineering (ASX:ANG), and the dismantling of key US safety regulator NIOSH.
  • Gross margins remain in-line with estimates around the ‘mid-70s’ and costs are well controlled.

Primer: UltraGreen.AI (ULG SP) – Dec 2025

By αSK

  • Market Leader in a High-Growth Niche: UltraGreen.AI is a global leader in the manufacturing and distribution of indocyanine green (ICG), a critical consumable for the rapidly expanding Fluorescence Guided Surgery (FGS) market. The FGS market is projected to experience robust double-digit compound annual growth, driven by the increasing adoption of minimally invasive and precision surgical techniques.
  • Strong Financial Profile with High Profitability: The company has demonstrated a track record of impressive revenue growth and consistently high-profitability margins. This financial strength is underpinned by its dominant market position and stable pricing power, particularly in the lucrative US market.
  • Strategic Shift Towards an AI-Powered Ecosystem: UltraGreen.AI is strategically evolving from a consumables provider to an integrated surgical intelligence platform. By combining its ICG products with proprietary imaging systems (IC-Flow™) and an AI-driven data analytics platform (PerfusionWorks™), the company aims to create a comprehensive ecosystem that enhances surgical decision-making and patient outcomes, creating significant barriers to entry.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


JTEC Corp (3446 JP) – Strength in Optical Remains, Progress in Semiconductor

By Astris Advisory Japan

  • A soft start – Q1 FY6/26 results were relatively soft, with sales flat and OP still in negative territory.
  • This reflects the seasonally weak nature of Q1 and continued spending on R&D.
  • The Optical segment remained strong, supported by resilient global demand, while the Life Science & Equipment Development segment continued to progress, driven by consumables, maintenance services, and semiconductor equipment currently in the testing stage. 

Kyowa Kirin (4151 JP): Ziftomenib Approval and Commercialization A Positive, What Lies Ahead?

By Tina Banerjee

  • Kyowa Kirin Co Ltd (4151 JP) announced that ziftomenib is now commercially available in the U.S. Company will be eligible for 50% profit sharing from drug sales in the U.S.
  • Rocatinlimab, under Phase 3 trials, represents a potentially novel upstream approach for the management of mild to severe atopic dermatitis. It is also undergoing Phase 3 trials for Prurigo nodularis.
  • 2026 will be an inflection point. Ziftomenib results will slowly fall in place. Positive results of rocatinlimab and new manufacturing facilities has potential to play out in long term.

Primer: Sysmex (6869 JT) – Dec 2025

By αSK

  • Sysmex is a global leader in the in-vitro diagnostics (IVD) market, with a dominant position in the hematology segment and a strong presence in urinalysis and hemostasis. The company’s business model is driven by the sale of diagnostic instruments and the recurring revenue from high-margin reagents.
  • Growth is supported by favorable long-term trends, including aging populations, rising prevalence of chronic diseases, and increasing healthcare access in emerging markets. Sysmex is strategically focused on expanding its footprint in these high-growth regions, particularly in Asia.
  • While the company has a strong track record of revenue growth and profitability, it faces challenges from intensifying competition, pricing pressure from healthcare cost-containment measures, and the need for continuous innovation to maintain its technological edge.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: ANE Cayman Inc, Adani Ports & Special Economic Zone, Spindex Industries, Tuhu Car , Legalzoom.com , Itoki Corp, Guangdong Tianyu Semiconductor, Tsubakimoto Kogyo, AF Legal Group Ltd and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?
  • Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN
  • Spindex Inds (SPE SP): 18th Dec Vote On MBO
  • Spindex Industries (SPE SP): Scheme Vote on 18 December
  • Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth
  • Primer: Legalzoom.com (LZ US) – Dec 2025
  • Itoki (7972 JP) – Capturing Structural Growth in the Future of Work
  • Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand
  • Tsubakimoto Kogyo (8052 JP) – Q2 Follow-Up
  • Primer: AF Legal Group Ltd (AFL AU) – Dec 2025


ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?

By Arun George

  • The consortium has decided NOT to exercise its right to increase the ANE Cayman Inc (9956 HK) share alternative cap from 5.00% to 7.50% of outstanding shares. 
  • The positive read-across is that it signals the consortium’s confidence that the vote will pass, as reflected in the quick decision not to lift the cap (deadline was 12 December). 
  • The negative readacross is that shareholders requesting the scrip option likely exceeded the 7.5% upper threshold, and the consortium is hoping that these shareholders will instead take the mix option.

Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN

By Manishi Raychaudhuri

  • Since inception (May 15th), our Model Portfolio has appreciated 17.0% – same as MSCI Asia-ex Japan.  Since the last rebalancing (7th November) our Portfolio declined 2.5% vs MXASJ’s 1.3% drop.
  • The recent underperformance came from drawdowns in Tencent Music, Tencent, Alibaba, Hynix, Hyundai Rotem, TSMC. We reduce the first two slightly, exclude BBCA, include Adani Ports, SCB, MAPI, HK Land.
  • We remain Overweight HK/China and Korea. We upgrade India to Overweight from Neutral, Thailand from Underweight to Neutral, and downgrade Indonesia to Underweight from Neutral. Stay Underweight Taiwan, Neutral Singapore.

Spindex Inds (SPE SP): 18th Dec Vote On MBO

By David Blennerhassett

  • On the 26th September, precision parts manufacturer Spindex Industries (SPE SP) announced an Offer, by way of a Scheme, from the Tan Family, Spindex’s controlling shareholder, with 74.95%.
  • The Tan’s offered S$1.43/share, an okay 27.7% premium to undisturbed; but a decade-high price. A A$0.02/share was also bolted on (& now paid). No competing Offer will emerge.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 18th December, and expected payment on the 11th Feb 2026. The IFA (Evolve Capital) says “fair & reasonable“.

Spindex Industries (SPE SP): Scheme Vote on 18 December

By Arun George

  • The Spindex Industries (SPE SP) IFA has opined that the Chairman and PrimeMovers Equity’s scheme offer of S$1.43 is fair and reasonable.
  • The offer is at the upper end of the IFA valuation range of S$0.71 and S$1.44. The offer is at adjusted NAV and is attractive compared to historical trading ranges.
  • The absence of a disinterested shareholder holding a blocking stake and moderate retail ownership reduces voting risk. This is a done deal.

Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth

By Mohshin Aziz

  • Tuhu sets up operations in Malaysia, its first overseas expansion outside of Greater China.
  • We think Tuhu can dominate the market within 3-4 years, as there are no local establishments that can match its infrastructure, know-how, and capital base. 
  • Fair value of HKD23 implies 22x FY26 PE – average for US peers. A bargain with 3-year CAGR of 30%, net cash, and churns high free cash flow.

Primer: Legalzoom.com (LZ US) – Dec 2025

By αSK

  • LegalZoom is the market leader in the online legal services industry, benefiting from strong brand recognition and a large customer base. The company is strategically shifting its focus towards higher-margin subscription services to create a more predictable, recurring revenue stream.
  • The company exhibits a strong financial profile with consistent revenue growth, expanding EBITDA margins, and a debt-free balance sheet. This financial stability supports investments in technology, strategic acquisitions, and share repurchase programs.
  • Key risks to the outlook include intense competition from both established players and new entrants, potential regulatory changes concerning the unauthorized practice of law, and a high dependency on the macroeconomic environment which influences the rate of new business formations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Itoki (7972 JP) – Capturing Structural Growth in the Future of Work

By Astris Advisory Japan

  • Structural demand meets sustained value creation – The role of the office is undergoing a structural shift—driven by talent attraction, hybrid work, wellness, and technology.
  • As a key domestic player in office design and furniture, we believe Itoki is well-positioned to benefit from this structural theme.
  • Post-COVID demand momentum remains steady, supported by rising investment in human capital, persistent labour shortages, and limited new office supply. 

Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand

By Nicholas Tan

  • Guangdong Tianyu Semiconductor (2223725D CH) raised around US$224m in its HK IPO.
  • It was founded in 2009, and is the largest domestic PRC SiC epitaxal wafer manufacturer both in terms of revenue and sales volume, as of 2024.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

Tsubakimoto Kogyo (8052 JP) – Q2 Follow-Up

By Sessa Investment Research

  • Tsubakimoto Kogyo Co., Ltd. (hereafter, the Company) announced H1 FY2026/3 results on October 31, 2025.
  • The Company worked through its large order backlog and delivered results in line with its plan, recording double-digit growth in both net sales and profit.
  • Although orders for China declined due to the absence of large projects and Nissan Motor’s production restructuring, this was offset by stronger demand for labor- saving equipment and other equipment-related products, allowing the Company to maintain order levels roughly the same level as the previous year, which SIR views positively.

Primer: AF Legal Group Ltd (AFL AU) – Dec 2025

By αSK

  • AFL is executing a roll-up strategy in the highly fragmented Australian family law market, driving strong revenue growth through acquisitions.
  • Significant profitability challenges persist, evidenced by a statutory net loss in 2023 and razor-thin margins in 2025, raising concerns about the sustainability of its acquisition-led model.
  • The company’s valuation appears stretched, with a P/E ratio of 100, which seems disconnected from its volatile earnings and the inherent risks of integrating numerous small law practices.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: SK Inc, Nikkei 225, Meesho, Synopsys Inc, Geechs Inc, Telecom Argentina , C3.ai Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • 2026 High Conviction Idea: SK Inc
  • 2026 High Conviction – Japan’s Triple Play: How PBR Reform, AI, and Banks Unlock Alpha
  • Meesho Ltd IPO- Watch Out for Impairment Allowance
  • Meesho Ltd IPO – Value-Led Play, Moderately Priced
  • NVIDIA Invests $2 Billion In Synopsys. But Why?
  • Meesho’s Valmo | Erosion of Delhivery’s Margins
  • Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025
  • Meesho:Data Science Workhorse;Fast Evolving—Venturing into Financial Services & Other AI Investments
  • Telecom 3Q25: Stronger Margins and a More Constructive Outlook
  • C3.ai, Inc. – IPDs and the Gross Margin Squeeze


2026 High Conviction Idea: SK Inc

By Douglas Kim

  • Three main reasons why SK Inc is our high conviction in 2026 include mandatory cancellation of treasury shares, deep discount to NAV, and the end of divorce for Chairman Chey. 
  • SK Inc has 17.98 million shares in treasury, representing 24.8% of outstanding shares. Among the stocks included in KOSPI200, this is one of the highest percentage of treasury shares.
  • Our NAV valuation analysis suggests NAV of 28 trillion won or NAV per share of 386,469 won. This represents a 46% upside to its current price.

2026 High Conviction – Japan’s Triple Play: How PBR Reform, AI, and Banks Unlock Alpha

By Jay Cameron

  • Sustained pressure from the JPX initiative targeting firms trading below P/B is forcing enhanced capital returns (buybacks and dividends), creating opportunity across both indices.
  • BoJ’s shift to a positive rate environment is fundamentally restoring Net Interest Income and profitability to the Financials sector, positioning the TOPIX, in particular, for outperformance.
  • AI/Tech Sector Dominance: The Nikkei 225 is driven by high-tech firms. This concentration, led by high-priced high weighted stocks like Advantest and Softbank Group, provides high-beta AI exposure

Meesho Ltd IPO- Watch Out for Impairment Allowance

By Nitin Mangal

  • Meesho (1546271D IN)‘s INR 52.4 bn IPO is currently open for subscription. It consists of fresh issue worth INR 42.5 bn and OFS component worth INR 11.7 bn 
  • The company is India’s largest E-Com platforms in terms of placed orders and user base, and make its mark in the value segment, offering mostly unbranded and regional branded products. 
  • While KPIs signal growth and operational efficiencies, Meesho is still a loss maker. It has high litigation risk and seeing rapid increase in impairments and write offs with receivables

Meesho Ltd IPO – Value-Led Play, Moderately Priced

By Akshat Shah

  • Meesho (1546271D IN) is looking to raise around US$607m in its upcoming India IPO.
  • Meesho is an e-commerce marketplace, offering a wide assortment of products ranging from low cost unbranded products, regional and national brands at affordable prices to consumers.
  • In our earlier notes, we have looked at the company’s past performance earlier. In this note, we talk about the implied valuations in the price range.

NVIDIA Invests $2 Billion In Synopsys. But Why?

By William Keating

  • NVIDIA & Synopsys announced a new strategic partnership on Dec 1, mostly covering topics they were already strategically partnering on, with one exception, Cloud-Ready Solutions
  • The partnership sees NVIDIA purchase $2 billion worth of Synopsys stock in a private placement. Other, recent, similar strategic partnerships e.g. Siemens & GM, involved no such investment
  • They plan to start enabling cloud access for GPU-accelerated engineering solutions. Could this be where that $2 billion finds a home? Is this a new Neocloud in disguise? Let’s see

Meesho’s Valmo | Erosion of Delhivery’s Margins

By Pranav Bhavsar

  • Delhivery (DELHIVER IN) faces immediate volume erosion as Meesho (1546271D IN) migrates 65% of orders to Valmo, destabilizing a key client relationship historically contributing ~16% of total revenue.
  • Valmo’s rise structurally shrinks the addressable 3PL market, creating a permanent headwind that compresses pricing power and intensifies competition for remaining open volumes.
  • Anchor client insourcing caps Delhivery’s growth trajectory, rendering the Ecom Express acquisition insufficient to offset the structural decay in organic B2C volume velocity.

Geechs (7060 Jp) – Q2 Follow-Up: November 28, 2025

By Sessa Investment Research

  • On November 13, Geechs Inc. (hereafter, “the Company”) announced its Q2 FY2026/3 (Jul-Sep) earnings results.
  • Net sales rose 2.5% YoY to JPY 6,518 mn, EBITDA rose 86% YoY to JPY 278 mn, and operating profit rose 124.9% YoY to JPY 253 mn.
  • In addition to steady expansion of the core Japan IT Human Resources Matching Business (hereafter, “Japan IT HRM Biz”), faster-than-expected profitability in the IT Human Resources Matching Business, Overseas (hereafter, “Overseas IT HRM Biz”) and stronger-than-planned growth in the Seed Tech business contributed to results. 

Meesho:Data Science Workhorse;Fast Evolving—Venturing into Financial Services & Other AI Investments

By Sreemant Dudhoria,CFA

  • In this insight, we highlight why Meesho (1546271D IN) is a data science workhorse masquerading as an E-Commerce Platform
  • We discuss about the various advancements made by the company towards AL/ML models which are difficult to replicate.
  • Finally, we discuss our view on future prospects and valuation of the company.

Telecom 3Q25: Stronger Margins and a More Constructive Outlook

By Leandro Gubler

  • We upgrade Telecom Argentina to Overweight as the TMA acquisition strengthens its market position, supports operating momentum, and benefits from reduced political risk and improving macro stability.
  • Regulatory uncertainty remains meaningful, and we think clearer visibility on the Telefónica approval process and integration timeline will be critical for value realization and credit performance.
  • • We see more value in the TEOAR 2031s given their lower duration, attractive relative spreads versus the EM B Index and peers, and supportive operating trends despite weak liquidity.

C3.ai, Inc. – IPDs and the Gross Margin Squeeze

By Water Tower Research

  • In-line 2QFY26 revenue and EBIT beat on cost controls, but gross margin pressure from IPDs. 
  • 2QFY26 revenue of $75.1 million was essentially on target and cost controls drove a better-than-expected bottom line with EBIT of ($42 million) [Street = ($52 million)]. 
  • However, non-GAAP gross margin was 54.5%, up 280 bps but more than 300 bps below Street expectations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: ANE Cayman Inc, Adani Ports & Special Economic Zone, Spindex Industries, Tuhu Car , Legalzoom.com , Itoki Corp, Guangdong Tianyu Semiconductor, Tsubakimoto Kogyo, AF Legal Group Ltd and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?
  • Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN
  • Spindex Inds (SPE SP): 18th Dec Vote On MBO
  • Spindex Industries (SPE SP): Scheme Vote on 18 December
  • Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth
  • Primer: Legalzoom.com (LZ US) – Dec 2025
  • Itoki (7972 JP) – Capturing Structural Growth in the Future of Work
  • Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand
  • Tsubakimoto Kogyo (8052 JP) – Q2 Follow-Up
  • Primer: AF Legal Group Ltd (AFL AU) – Dec 2025


ANE (9956 HK): Tempting Fate Through an Unchanged Share Alternative Cap?

By Arun George

  • The consortium has decided NOT to exercise its right to increase the ANE Cayman Inc (9956 HK) share alternative cap from 5.00% to 7.50% of outstanding shares. 
  • The positive read-across is that it signals the consortium’s confidence that the vote will pass, as reflected in the quick decision not to lift the cap (deadline was 12 December). 
  • The negative readacross is that shareholders requesting the scrip option likely exceeded the 7.5% upper threshold, and the consortium is hoping that these shareholders will instead take the mix option.

Asian Equities: Rebalancing Our Model Portfolio – More to India and ASEAN

By Manishi Raychaudhuri

  • Since inception (May 15th), our Model Portfolio has appreciated 17.0% – same as MSCI Asia-ex Japan.  Since the last rebalancing (7th November) our Portfolio declined 2.5% vs MXASJ’s 1.3% drop.
  • The recent underperformance came from drawdowns in Tencent Music, Tencent, Alibaba, Hynix, Hyundai Rotem, TSMC. We reduce the first two slightly, exclude BBCA, include Adani Ports, SCB, MAPI, HK Land.
  • We remain Overweight HK/China and Korea. We upgrade India to Overweight from Neutral, Thailand from Underweight to Neutral, and downgrade Indonesia to Underweight from Neutral. Stay Underweight Taiwan, Neutral Singapore.

Spindex Inds (SPE SP): 18th Dec Vote On MBO

By David Blennerhassett

  • On the 26th September, precision parts manufacturer Spindex Industries (SPE SP) announced an Offer, by way of a Scheme, from the Tan Family, Spindex’s controlling shareholder, with 74.95%.
  • The Tan’s offered S$1.43/share, an okay 27.7% premium to undisturbed; but a decade-high price. A A$0.02/share was also bolted on (& now paid). No competing Offer will emerge.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 18th December, and expected payment on the 11th Feb 2026. The IFA (Evolve Capital) says “fair & reasonable“.

Spindex Industries (SPE SP): Scheme Vote on 18 December

By Arun George

  • The Spindex Industries (SPE SP) IFA has opined that the Chairman and PrimeMovers Equity’s scheme offer of S$1.43 is fair and reasonable.
  • The offer is at the upper end of the IFA valuation range of S$0.71 and S$1.44. The offer is at adjusted NAV and is attractive compared to historical trading ranges.
  • The absence of a disinterested shareholder holding a blocking stake and moderate retail ownership reduces voting risk. This is a done deal.

Tuhu Car (9690 HK | BUY | TP:HKD23): Tuhu Goes International, the Next Engine of Growth

By Mohshin Aziz

  • Tuhu sets up operations in Malaysia, its first overseas expansion outside of Greater China.
  • We think Tuhu can dominate the market within 3-4 years, as there are no local establishments that can match its infrastructure, know-how, and capital base. 
  • Fair value of HKD23 implies 22x FY26 PE – average for US peers. A bargain with 3-year CAGR of 30%, net cash, and churns high free cash flow.

Primer: Legalzoom.com (LZ US) – Dec 2025

By αSK

  • LegalZoom is the market leader in the online legal services industry, benefiting from strong brand recognition and a large customer base. The company is strategically shifting its focus towards higher-margin subscription services to create a more predictable, recurring revenue stream.
  • The company exhibits a strong financial profile with consistent revenue growth, expanding EBITDA margins, and a debt-free balance sheet. This financial stability supports investments in technology, strategic acquisitions, and share repurchase programs.
  • Key risks to the outlook include intense competition from both established players and new entrants, potential regulatory changes concerning the unauthorized practice of law, and a high dependency on the macroeconomic environment which influences the rate of new business formations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Itoki (7972 JP) – Capturing Structural Growth in the Future of Work

By Astris Advisory Japan

  • Structural demand meets sustained value creation – The role of the office is undergoing a structural shift—driven by talent attraction, hybrid work, wellness, and technology.
  • As a key domestic player in office design and furniture, we believe Itoki is well-positioned to benefit from this structural theme.
  • Post-COVID demand momentum remains steady, supported by rising investment in human capital, persistent labour shortages, and limited new office supply. 

Guangdong Tianyu IPO Trading: Weak Insti and Retail Demand

By Nicholas Tan

  • Guangdong Tianyu Semiconductor (2223725D CH) raised around US$224m in its HK IPO.
  • It was founded in 2009, and is the largest domestic PRC SiC epitaxal wafer manufacturer both in terms of revenue and sales volume, as of 2024.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

Tsubakimoto Kogyo (8052 JP) – Q2 Follow-Up

By Sessa Investment Research

  • Tsubakimoto Kogyo Co., Ltd. (hereafter, the Company) announced H1 FY2026/3 results on October 31, 2025.
  • The Company worked through its large order backlog and delivered results in line with its plan, recording double-digit growth in both net sales and profit.
  • Although orders for China declined due to the absence of large projects and Nissan Motor’s production restructuring, this was offset by stronger demand for labor- saving equipment and other equipment-related products, allowing the Company to maintain order levels roughly the same level as the previous year, which SIR views positively.

Primer: AF Legal Group Ltd (AFL AU) – Dec 2025

By αSK

  • AFL is executing a roll-up strategy in the highly fragmented Australian family law market, driving strong revenue growth through acquisitions.
  • Significant profitability challenges persist, evidenced by a statutory net loss in 2023 and razor-thin margins in 2025, raising concerns about the sustainability of its acquisition-led model.
  • The company’s valuation appears stretched, with a P/E ratio of 100, which seems disconnected from its volatile earnings and the inherent risks of integrating numerous small law practices.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars